Other
A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
Organic letters · 12 Jun 2026
Record
Publication details
- Authors
- Mao CY, Pang ZJ, Qiao GY, Dong L
- Journal
- Organic letters
- Publication date
- 12 Jun 2026
- Publication type
- Journal Article
- Evidence type
- Other
- Relevance classification
- Primary
- PubMed ID
- 42224238
- DOI
- 10.1021/acs.orglett.6c02001
- Language
- eng
- Linked clinical trial
- Not reported
Abstract
Retatrutide is a novel triple agonist that targets the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R). At present, its synthesis relies predominantly on solid-phase peptide synthesis (SPPS), an approach that suffers from inherent limitations in terms of efficiency, scalability, and structural flexibility. In this study, we present a novel method for the synthesis of Retatrutide, namely hydrophobic tag-assisted liquid-phase peptide synthesis (LPPS). This method provides a practical and flexible alternative to conventional SPPS for the synthesis of Retatrutide.
Weekly briefing
The Retatrutide Report
The most important retatrutide clinical trial, research and regulatory developments, once a week.
No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.